ES8300758A1 - Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas. - Google Patents

Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas.

Info

Publication number
ES8300758A1
ES8300758A1 ES503308A ES503308A ES8300758A1 ES 8300758 A1 ES8300758 A1 ES 8300758A1 ES 503308 A ES503308 A ES 503308A ES 503308 A ES503308 A ES 503308A ES 8300758 A1 ES8300758 A1 ES 8300758A1
Authority
ES
Spain
Prior art keywords
oxadiazol
ones
same
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES503308A
Other languages
English (en)
Spanish (es)
Other versions
ES503308A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES503308A0 publication Critical patent/ES503308A0/es
Publication of ES8300758A1 publication Critical patent/ES8300758A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES503308A 1980-06-27 1981-06-23 Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas. Expired ES8300758A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/163,614 US4309430A (en) 1980-06-27 1980-06-27 Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same

Publications (2)

Publication Number Publication Date
ES503308A0 ES503308A0 (es) 1982-11-01
ES8300758A1 true ES8300758A1 (es) 1982-11-01

Family

ID=22590790

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503308A Expired ES8300758A1 (es) 1980-06-27 1981-06-23 Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas.

Country Status (10)

Country Link
US (1) US4309430A (cg-RX-API-DMAC7.html)
EP (1) EP0043123B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5756480A (cg-RX-API-DMAC7.html)
AT (1) ATE7697T1 (cg-RX-API-DMAC7.html)
DE (1) DE3163867D1 (cg-RX-API-DMAC7.html)
DK (1) DK283881A (cg-RX-API-DMAC7.html)
ES (1) ES8300758A1 (cg-RX-API-DMAC7.html)
GR (1) GR74609B (cg-RX-API-DMAC7.html)
IE (1) IE51342B1 (cg-RX-API-DMAC7.html)
PT (1) PT73259B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
EP2370424A1 (en) 2008-11-10 2011-10-05 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
SI3354650T1 (sl) 2008-12-19 2022-06-30 Vertex Pharmaceuticals Incorporated Spojine, uporabne kot zaviralci ATR kinaze
EP2569287B1 (en) 2010-05-12 2014-07-09 Vertex Pharmaceuticals Inc. Compounds useful as inhibitors of atr kinase
AU2011253025A1 (en) 2010-05-12 2012-11-29 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2011143419A1 (en) 2010-05-12 2011-11-17 Vertex Pharmaceuticals Incorporated Pyrazines useful as inhibitors of atr kinase
AU2011253021A1 (en) 2010-05-12 2012-11-29 Vertex Pharmaceuticals Incorporated 2 -aminopyridine derivatives useful as inhibitors of ATR kinase
EP2568984A1 (en) 2010-05-12 2013-03-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
JP2013529200A (ja) 2010-05-12 2013-07-18 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
AU2011270807A1 (en) 2010-06-23 2013-01-31 Vertex Pharmaceuticals Incorporated Pyrrolo- pyrazine derivatives useful as inhibitors of ATR kinase
MX2013011450A (es) 2011-04-05 2014-02-03 Vertex Pharma Compuestos de aminopirazina utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr).
JP2014522818A (ja) 2011-06-22 2014-09-08 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
EP2723745A1 (en) 2011-06-22 2014-04-30 Vertex Pharmaceuticals Inc. Compounds useful as inhibitors of atr kinase
JP2014517079A (ja) 2011-06-22 2014-07-17 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
BR112014007690B1 (pt) 2011-09-30 2022-10-04 Vertex Pharmaceuticals Incorporated Usos de inibidores de atr no tratamento de câncer pancreático e câncer de pulmão de células não pequenas
EP2751088B1 (en) 2011-09-30 2016-04-13 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
JP6212045B2 (ja) 2011-09-30 2017-10-11 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Atrキナーゼの阻害剤として有用な化合物を作製するためのプロセス
WO2013049720A1 (en) 2011-09-30 2013-04-04 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
MX2014003796A (es) 2011-09-30 2015-01-16 Vertex Pharma Compuestos utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr).
EP2776420A1 (en) 2011-11-09 2014-09-17 Vertex Pharmaceuticals Incorporated Pyrazine compounds useful as inhibitors of atr kinase
US8841337B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2013071094A1 (en) 2011-11-09 2013-05-16 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US8841449B2 (en) 2011-11-09 2014-09-23 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
US8846917B2 (en) 2011-11-09 2014-09-30 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
DK2833973T3 (en) 2012-04-05 2018-01-02 Vertex Pharma Compounds useful as ATR kinase inhibitors and combination therapies thereof
US8999632B2 (en) 2012-10-04 2015-04-07 Vertex Pharmaceuticals Incorporated Method for measuring ATR inhibition mediated increases in DNA damage
EP2909202A1 (en) 2012-10-16 2015-08-26 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP3418281B1 (en) 2012-12-07 2020-09-30 Vertex Pharmaceuticals Inc. Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
EP2970286A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
EP3077397B1 (en) 2013-12-06 2019-09-18 Vertex Pharmaceuticals Inc. 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
ES2777608T3 (es) 2014-06-05 2020-08-05 Vertex Pharma Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo
CA2950780C (en) 2014-06-17 2023-05-16 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of chk1 and atr inhibitors
WO2017059357A1 (en) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna damaging agents and atr inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515723A (en) * 1967-11-14 1970-06-02 Merck & Co Inc 2 - (5 - amino - 1h - 1,2,4 - triazol - 3 - yl)- 3-aminopyrazines and processes for their preparation
US3770739A (en) * 1972-09-11 1973-11-06 American Cyanamid Co Cyclorpropyl-1,2,4-oxadiazolylpyrazines

Also Published As

Publication number Publication date
ES503308A0 (es) 1982-11-01
DK283881A (da) 1981-12-28
US4309430A (en) 1982-01-05
PT73259B (en) 1983-06-28
IE51342B1 (en) 1986-12-10
EP0043123A1 (en) 1982-01-06
ATE7697T1 (de) 1984-06-15
PT73259A (en) 1981-07-01
IE811431L (en) 1981-12-27
EP0043123B1 (en) 1984-05-30
JPS5756480A (en) 1982-04-05
GR74609B (cg-RX-API-DMAC7.html) 1984-06-29
DE3163867D1 (en) 1984-07-05

Similar Documents

Publication Publication Date Title
ES8300758A1 (es) Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas.
ES8205789A1 (es) Un procedimiento para la preparacion de derivados del indol
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8306122A1 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES8303383A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
ES8601907A1 (es) Procedimiento para preparar imidazolinas.
ES480053A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ES8801284A1 (es) Procedimiento para preparar nuevos compuestos de benzotiofeno y benzofurano
ES8707925A1 (es) Un procedimiento para la preparacion de derivados de aminofenol
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8506707A1 (es) Un derivado de acido tiazolilacetico
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
DK211283A (da) Benzothiazolinforbindelser
ES8105721A1 (es) Un procedimiento para la preparacion de nuevos 1, 2, 4-tria-zoles.
EP0010652B1 (de) Neue 4-Chloroxazole, Verfahren zu deren Herstellung und deren Verwendung in photoleitenden Schichten in der Elektrophotographie und als optische Aufheller
ES8601210A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
ES8205215A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido acetico.
ES8401485A1 (es) Un procedimiento de preparacion de nuevas 8-(3-(1,2-bencisoxazol-3-il)propil)-1-fenil-1,3,8-triazaspiro(4,5)decan-4-onas.
ES8500907A1 (es) Procedimiento para preparar derivados de (indenil-2)-2-imidazolina
Yamashita Iodine-catalyzed thermal cis-trans isomerization of azobenzene
ES8407482A1 (es) Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos.
SE8502973D0 (sv) Framstellning av aminderivat
GB1341204A (en) Process for the manufacture of triarylmethane compounds
GB1352089A (en) Bis-styryltriazoles their use for the optical brightening of organic materials and processes for their manufacture